https://www.fiercepharma.com/marketing/gsks-arexvy-lead-new-rsv-vaccines-sales-race-moderna-close-second-report
0
0
GSK's Arexvy to lead new RSV vaccines sales race with Moderna a close second: report - FiercePharma
7/24/23 at 2:44pm
Organization
FiercePharma
Author
FiercePharma
Details
17 words
Summarize
Create an account or login to join the discussion